UNSPSC 51162007: Aminophylline/ephedrine/phenobarbital/potassium iodide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE109. This VA Drug Class (RE109) classifies this compound as belonging to the group ANTIASTHMA, OTHER.

UNSPSC 51162007 Aminophylline/ephedrine/phenobarbital/potassium iodide (Commodity) encompasses pharmaceutical products and pharmacy services, though recent state and local solicitations under this code show limited direct alignment with the nominal commodity name. State and local governments are actually procuring naloxone and drug deactivation systems for community health programs, on-site pharmacy services for employee health plans, and generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing arrangements. Issuing bodies include county health departments, county government employee benefit programs, state health and human services agencies, and state departments of administration administering multistate cooperative purchasing vehicles. Solicitations vary from direct supply arrangements to full-service pharmacy operations supporting thousands of eligible individuals.

Recent activity spans Florida, Georgia, Texas, and Minnesota. Seminole County, Florida issued an IFB (IFB60459723LAS) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building, with a response deadline of July 26, 2023. Hall County, Georgia released an RFQ/P (#47-010) in May 2026 for on-site pharmacy services at its Family Health Center Clinic serving approximately 3,005 eligible individuals across three health insurance plans, with proposals due June 4, 2026. The Texas Health and Human Services Commission issued an RFI (HHS0017013) in April 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements. The Minnesota Department of Administration's Office of State Procurement, administering the MMCAP multistate cooperative purchasing vehicle, issued an RFP (S1070000015802) in January 2026 for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, with proposals due March 26, 2026. The code shows modest recent activity concentrated in the Southeast and Upper Midwest, with scope spanning both consumer health products and institutional pharmacy operations.